PTC治疗 PTCT 深 沪
已收盘 08-08 16:00:00 美东时间
45.38
-4.980
-9.89%
华盛通- 最 高48.359
- 今 开45.00
- 成交量 236.30万股
- 最 低 45.00
- 昨 收 50.36
- 总市值 35.97亿
- 52周最高 58.38
- 市盈率 静 --
- 换手率 2.98%
- 52周最低 30.41
- 委 比 -61.03%
- 总股本 7925.70万
- 历史最高 78.72
- 量 比 2.54
- 振 幅 6.67%
- 历史最低 4.03
- 每 手 1
- 风险率 6.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PTC Therapeutics outlines Sephience $1B-plus U.S. revenue potential following FDA and EU launches
Earnings Call Insights: PTC Therapeutics (PTCT) Q2 2025 Management View CEO Matthew B. Klein opened the call highlighting the "first approvals for Sephience for the treatment of children and adults wi...
08-09 03:19
Wells Fargo Maintains Overweight on PTC Therapeutics, Raises Price Target to $79
Wells Fargo analyst Tiago Fauth maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $78 to $79.
08-08 23:26
PTC Therapeutics Enters Rights Satisfaction Agreement
The latest announcement is out from PTC Therapeutics ( ($PTCT) ). On August 5, ...
08-08 05:49
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
PTC Therapeutics Earnings Preview
PTC Therapeutics (NASDAQ:PTCT) is gearing up to announce its quarterly earnings...
08-07 01:02
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
08-06 02:25
重磅！全球十大最贵药物之一首次在国内报上市
（来源：抗体圈） 截图来源：CDE 官网 Zolgensma 是一款用于治疗脊髓性肌萎缩症（SMA）的基因疗法，其独特优势在于通过单次静脉注射，就能让...
08-04 10:51
SA analyst upgrades/downgrades: AMD, TSLA, SHEL, PTCT
Advanced Micro Devices (AMD) and Tesla (TSLA) have been downgraded by Seeking Alpha analysts due to valuation concerns, while Shell (SHEL) receives an upgrade on improved production outlooks. PTC Ther...
08-02 00:38
